14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0200 $0.0500 Friday, 3rd May 2024 CALA stock ended at $0.0200. During the day the stock fluctuated 0% from a day low at $0.0200 to a day high of $0.0200.
90 days $0.0200 $0.120
52 weeks $0.0150 $0.500

Historical Calithera Biosciences prices

Date Open High Low Close Volume
Jan 18, 2022 $0.540 $0.540 $0.503 $0.504 502 600
Jan 14, 2022 $0.540 $0.546 $0.523 $0.542 302 800
Jan 13, 2022 $0.580 $0.580 $0.541 $0.547 534 200
Jan 12, 2022 $0.590 $0.600 $0.562 $0.573 386 800
Jan 11, 2022 $0.580 $0.605 $0.575 $0.582 486 800
Jan 10, 2022 $0.596 $0.599 $0.565 $0.576 477 800
Jan 07, 2022 $0.615 $0.630 $0.590 $0.601 441 600
Jan 06, 2022 $0.620 $0.630 $0.590 $0.607 379 500
Jan 05, 2022 $0.641 $0.663 $0.620 $0.621 569 600
Jan 04, 2022 $0.683 $0.695 $0.642 $0.645 483 727
Jan 03, 2022 $0.665 $0.682 $0.660 $0.678 522 608
Dec 31, 2021 $0.620 $0.730 $0.620 $0.665 2 379 460
Dec 30, 2021 $0.620 $0.646 $0.612 $0.627 1 360 843
Dec 29, 2021 $0.680 $0.680 $0.618 $0.625 1 231 032
Dec 28, 2021 $0.700 $0.715 $0.669 $0.669 821 039
Dec 27, 2021 $0.740 $0.740 $0.671 $0.676 1 132 368
Dec 23, 2021 $0.682 $0.750 $0.682 $0.720 1 160 935
Dec 22, 2021 $0.680 $0.719 $0.671 $0.694 1 087 718
Dec 21, 2021 $0.685 $0.690 $0.670 $0.680 575 273
Dec 20, 2021 $0.670 $0.693 $0.660 $0.677 859 321
Dec 17, 2021 $0.700 $0.719 $0.658 $0.664 2 876 661
Dec 16, 2021 $0.700 $0.720 $0.692 $0.692 269 190
Dec 15, 2021 $0.702 $0.720 $0.680 $0.709 810 348
Dec 14, 2021 $0.730 $0.758 $0.713 $0.718 843 543
Dec 13, 2021 $0.770 $0.780 $0.730 $0.750 611 898
Click to get the best stock tips daily for free!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT